Position in INSM
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$60,192,856
+$283,415 QoQ
Shares Held
368,107
+6.9% QoQ
Ownership
0.170%
of shares outstanding
% of Portfolio
0.27%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
22 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in INSM Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Polar Capital Holdings Plc holds $3,129,351,296 across 43 Biotechnology names. INSM ranks #18 (1.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | XENE |
Xenon Pharmaceuticals Inc.
|
4,405,312 | $256,168,892 | |
| 2 | ELVN |
Enliven Therapeutics, Inc.
|
5,065,933 | $198,584,573 | |
| 3 | NUVL |
Nuvalent, Inc.
|
1,831,253 | $187,611,869 | |
| 4 | BBIO |
BridgeBio Pharma, Inc.
|
2,519,306 | $187,083,663 | |
| 5 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
289,310 | $151,445,105 | |
| 6 | ASND |
Ascendis Pharma A/S
|
651,712 | $149,066,085 | |
| 7 | REGN |
Regeneron Pharmaceuticals, Inc.
|
192,546 | $148,768,741 | |
| 8 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
1,615,586 | $140,507,514 |
All Filings in INSM
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $60,192,856 | 368,107 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $59,909,441 | 344,228 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $53,555,446 | 371,887 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $70,242,694 | 697,960 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $55,596,718 | 728,755 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $50,399,200 | 730,000 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $49,640,000 | 680,000 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $17,085,000 | 255,000 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $6,828,621 | 251,700 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $15,627,482 | 504,275 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $21,750,350 | 861,400 | Shares | Defined | 2023-11-22 | |
| 2023-06-30 | $35,687,463 | 1,691,349 | Shares | Defined | 2023-12-13 | |
| 2023-03-31 | $28,837,500 | 1,691,349 | Shares | Defined | 2023-12-13 | |
| 2022-12-31 | $30,796,153 | 1,541,349 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $29,969,657 | 1,391,349 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $12,460,062 | 631,849 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $14,848,451 | 631,849 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $48,983,213 | 1,798,209 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $49,522,675 | 1,798,209 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $26,651,025 | 936,438 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $31,895,078 | 936,438 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $23,346,310 | 701,301 | Shares | Sole | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||